Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Detaylı Bibliyografya
Yazar:	Karim, Samia Binte
Diğer Yazarlar:	Azam, Faruque
Materyal Türü:	Tez
Dil:	English
Baskı/Yayın Bilgisi:	Brac University 2024
Konular:	NSCLC Median age Clinical trial Combination size Clinical trials > Computer simulation Lung > Cancer Therapeutics
Online Erişim:	http://hdl.handle.net/10361/23944

Benzer Materyaller

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
Yazar:: Hoque, Ismoth Ara
Baskı/Yayın Bilgisi: (2024)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Yazar:: Paul, Pulock
Baskı/Yayın Bilgisi: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
Yazar:: Rahman, Tasnim
Baskı/Yayın Bilgisi: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Yazar:: Flora, Sanzida Alam
Baskı/Yayın Bilgisi: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
Yazar:: Hasan, Sakib
Baskı/Yayın Bilgisi: (2024)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
Yazar:: Shobnam, Sohana
Baskı/Yayın Bilgisi: (2024)

The hidden histories of war crimes trials /

A review on drug repurposing for diabetes epidemic
Yazar:: Lamia, Sadia Raisa
Baskı/Yayın Bilgisi: (2022)

A systematic review on the efficacy of Fluoxetine in the management of anxiety disorders
Yazar:: Akter, Rabia
Baskı/Yayın Bilgisi: (2024)

Update on pharmacological aspects of carotenoids: molecules of pharmaceutical promise
Yazar:: Labanna, Marium Akther
Baskı/Yayın Bilgisi: (2022)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
Yazar:: Oishy, Jannatun Noor
Baskı/Yayın Bilgisi: (2024)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
Yazar:: Das, Reshita
Baskı/Yayın Bilgisi: (2024)

Gene therapy for rare genetic disorders
Yazar:: Tanjum, Atia
Baskı/Yayın Bilgisi: (2024)

Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT‑SHOCK trial
Yazar:: Robles‑Zurita, Jose Antonio, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Zinc and human health : results of recent trials and implications for program interventions and research /
Baskı/Yayın Bilgisi: (2000)

The language of sexual misconduct cases
Yazar:: Shuy, Roger W.

Moot Court : pre-trail preparation and participation in trial proceedings /
Yazar:: Gupta, Sant Prasad
Baskı/Yayın Bilgisi: (2007)

Power, Powerlessness and Addiction
Yazar:: Jim Orford
Baskı/Yayın Bilgisi: (2013)

The Origins of Health and Disease
Yazar:: Michael E. Hyland
Baskı/Yayın Bilgisi: (2012)

Memory, War and Trauma
Yazar:: Nigel C. Hunt
Baskı/Yayın Bilgisi: (2012)

Trauma and Forgiveness
Yazar:: C. Fred Alford
Baskı/Yayın Bilgisi: (2013)

In-vitro preformulation studies for the development of a novel antidiabetic combination therapy involving linagliptin and dextromethorphan
Yazar:: Shishir, Tushar Ahmed
Baskı/Yayın Bilgisi: (2018)

A good mix against ultra-poverty? Evidence from a Randomized Controlled Trial (RCT) in Bangladesh
Yazar:: Rahman, Atiya, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

ব্র্যাক বিশ্ববিদ্যালয়ে ক্যারিয়ার ক্লিনিক
Yazar:: দৈনিক প্রথম আলো
Baskı/Yayın Bilgisi: (2013)

Clinical medicine : a textbook for medical students and doctors /
Baskı/Yayın Bilgisi: (1994)

Principles of clinical pharmacology /
Baskı/Yayın Bilgisi: (2012)

Molecules associated with the development of lung cancer
Yazar:: Rahman, Adree, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

A review on Metastatic Melanoma combination therapy Ipilimumab-Nivolumab
Yazar:: Chakraborty, Anupama
Baskı/Yayın Bilgisi: (2024)

Ceremonies of bravery
Yazar:: Maguire, J. Robert

Tell me your dreams /
Yazar:: Sheldon, Sidney
Baskı/Yayın Bilgisi: (1998)

সত্য মামলা আগরতলা /
Yazar:: আলী, শওকত, ১৯৩৭-

Safety and efficacy of cisplatin combinations with vinorelbine, paclitaxel and gemcitabine – a systematic review and meta-analysis
Yazar:: Islam, Inaya
Baskı/Yayın Bilgisi: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
Yazar:: Jeba, Joynob
Baskı/Yayın Bilgisi: (2017)

আগরতলা ষড়যন্ত্র মামলা : প্রাসঙ্গিক দলিলপত্র /
Yazar:: বেগম, সাহিদা

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
Yazar:: Monayem, Kazi Fahim
Baskı/Yayın Bilgisi: (2024)

Open source, low cost combine harvester
Yazar:: Sazim, Md. Abdullah Bin, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
Yazar:: Khan, Muidul Hasan
Baskı/Yayın Bilgisi: (2024)

A review on targeted therapies for lung cancer
Yazar:: Ashraf, Anushey
Baskı/Yayın Bilgisi: (2023)

Cluster-randomised controlled trials of individual and combined water, sanitation, hygiene and nutritional interventions in rural Bangladesh and Kenya: the WASH benefits study design and rationale
Yazar:: F. Arnold, Benjamin, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
Yazar:: Haque, Mushfiqul
Baskı/Yayın Bilgisi: (2019)